• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染对体重1000克及以下早产儿动脉导管未闭和慢性肺病的影响。

Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less.

作者信息

Gonzalez A, Sosenko I R, Chandar J, Hummler H, Claure N, Bancalari E

机构信息

Department of Pediatrics, Division of Neonatology, University of Miami School of Medicine, Florida, USA.

出版信息

J Pediatr. 1996 Apr;128(4):470-8. doi: 10.1016/s0022-3476(96)70356-6.

DOI:10.1016/s0022-3476(96)70356-6
PMID:8618179
Abstract

OBJECTIVES

To test the hypotheses that (1) infection increases ductal dilatory prostaglandins and inflammatory mediators that may influence the closure of a patent ductus arteriosus (PDA), increasing the incidence of late episodes of PDA (after 7 days) and the rate of closure failures, and (2) the concurrence of PDA and infection increases the risk of chronic lung disease (CLD).

METHODS

One hundred fourteen premature infants (birth weight, 500 to 1000 gm) were prospectively assessed for PDA and infection. Serum levels of 6-ketoprostaglandin F1 alpha and tumor necrosis factor alpha were measured routinely in all infants and when PDA or infection was present. Multivariate assessment of risk factors for PDA closure failure and for CLD was done by logistic regression, and expressed as an odds ratio and as 95% confidence intervals.

RESULTS

Late PDA episodes were more frequent in infants with infection than in those without infection. A temporally related infection (<5 days between both diagnoses) was associated with an increased risk of PDA closure failure (odds ratio, 19.1 (confidence interval, 4 to 90)). In addition to birth weight and the severity of initial respiratory failure, PDA and infection increased the risk of CLD (odds ratio, 11.7 (confidence interval, 1.7 to 81) for PDA; odds ration, 3.1 (confidence interval, 1 to 11) for infection). Furthermore, when both factors were temporally related, they further increased the risk of CLD (odds ratio, 29.6 (confidence interval, 4.5 to >100)). Infants with infection and those with PDA had higher levels of 6-ketoprostaglandin F1 alpha than did control subjects. Levels of tumor necrosis factor alpha were also elevated in infants with infection and in those with late PDA.

CONCLUSIONS

Infection adversely influences PDA outcome by increasing the risk of late ductal reopening and PDA closure failures. Increased levels of prostaglandins and tumor necrosis factor alpha in infants with infection may explain the poor PDA outcome. The concurrence of PDA and infection potentiates their negative effects on the risk of CLD.

摘要

目的

验证以下假设:(1)感染会增加导管扩张性前列腺素和炎症介质,这些物质可能影响动脉导管未闭(PDA)的闭合,从而增加PDA晚期发作(7天后)的发生率和闭合失败率;(2)PDA与感染同时存在会增加慢性肺病(CLD)的风险。

方法

对114例早产儿(出生体重500至1000克)进行前瞻性PDA和感染评估。所有婴儿在常规情况下以及出现PDA或感染时,均检测血清6-酮前列腺素F1α和肿瘤坏死因子α水平。通过逻辑回归对PDA闭合失败和CLD的危险因素进行多变量评估,并以比值比和95%置信区间表示。

结果

感染婴儿的PDA晚期发作比未感染婴儿更频繁。时间上相关的感染(两次诊断间隔<5天)与PDA闭合失败风险增加相关(比值比,19.1(置信区间,4至90))。除出生体重和初始呼吸衰竭的严重程度外,PDA和感染会增加CLD的风险(PDA的比值比,11.7(置信区间,1.7至81);感染的比值比,3.1(置信区间,1至11))。此外,当这两个因素在时间上相关时,它们会进一步增加CLD的风险(比值比,29.6(置信区间,4.5至>100))。感染婴儿和PDA婴儿的6-酮前列腺素F1α水平高于对照组。感染婴儿和晚期PDA婴儿的肿瘤坏死因子α水平也升高。

结论

感染通过增加导管晚期重新开放和PDA闭合失败的风险,对PDA的转归产生不利影响。感染婴儿中前列腺素和肿瘤坏死因子α水平升高可能解释了PDA转归不良的原因。PDA与感染同时存在会增强它们对CLD风险的负面影响。

相似文献

1
Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less.感染对体重1000克及以下早产儿动脉导管未闭和慢性肺病的影响。
J Pediatr. 1996 Apr;128(4):470-8. doi: 10.1016/s0022-3476(96)70356-6.
2
Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.新生儿慢性肺疾病流行病学及发病机制的变化趋势
J Pediatr. 1995 Apr;126(4):605-10. doi: 10.1016/s0022-3476(95)70362-4.
3
Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产儿和/或低出生体重儿的动脉导管未闭。
Cochrane Database Syst Rev. 2003(2):CD003481. doi: 10.1002/14651858.CD003481.
4
Lung function in very low birth weight infants after pharmacological and surgical treatment of patent ductus arteriosus - a retrospective analysis.动脉导管未闭药物及手术治疗后极低出生体重儿的肺功能——一项回顾性分析
BMC Pediatr. 2017 Jan 6;17(1):5. doi: 10.1186/s12887-016-0762-z.
5
Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.吲哚美辛长疗程与短疗程治疗早产儿动脉导管未闭的比较。
Cochrane Database Syst Rev. 2004(1):CD003480. doi: 10.1002/14651858.CD003480.pub2.
6
Patent ductus arteriosus in premature infants: to treat or not to treat?早产儿动脉导管未闭:治疗还是不治疗?
J Perinatol. 2017 Jun;37(6):652-657. doi: 10.1038/jp.2017.4. Epub 2017 Feb 16.
7
Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.口服布洛芬混悬液用于早产儿动脉导管未闭的闭合:一项初步研究。
Pediatrics. 2003 Nov;112(5):e354. doi: 10.1542/peds.112.5.e354.
8
Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus.
Pediatrics. 2000 Feb;105(2):320-4. doi: 10.1542/peds.105.2.320.
9
Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.吲哚美辛抑制宫缩会增加出生后动脉导管未闭的严重程度。
Pediatrics. 1998 Nov;102(5):E56. doi: 10.1542/peds.102.5.e56.
10
Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus.极低出生体重儿动脉导管重新开放的临床特征
Pediatr Int. 2011 Jun;53(3):322-7. doi: 10.1111/j.1442-200X.2010.03251.x.

引用本文的文献

1
The Timing and Factor of Ductus Arteriosus Closure in Infants with Down Syndrome Born at Term and Late-Preterm.足月和晚期早产儿唐氏综合征患儿动脉导管关闭的时间及因素
Pediatr Cardiol. 2025 Apr 21. doi: 10.1007/s00246-025-03869-7.
2
Morbidity and neurodevelopmental outcomes at 2 years in preterm infants undergoing percutaneous transcatheter closure vs. surgical ligation of the PDA.经皮导管介入封堵与外科结扎治疗早产儿动脉导管未闭的发病率和神经发育结局 2 年随访。
J Perinatol. 2024 Oct;44(10):1454-1462. doi: 10.1038/s41372-024-02019-w. Epub 2024 Jun 3.
3
The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation.
白细胞介素-1在围产期炎症中的作用及其对过渡循环的影响。
Front Pediatr. 2023 Mar 13;11:1130013. doi: 10.3389/fped.2023.1130013. eCollection 2023.
4
Association between endotypes of prematurity and pharmacological closure of patent ductus arteriosus: A systematic review and meta-analysis.早产内型与动脉导管未闭药物闭合之间的关联:一项系统评价和荟萃分析。
Front Pediatr. 2023 Mar 3;11:1078506. doi: 10.3389/fped.2023.1078506. eCollection 2023.
5
The Association of Patent Ductus Arteriosus with Inflammation: A Narrative Review of the Role of Inflammatory Biomarkers and Treatment Strategy in Premature Infants.动脉导管未闭与炎症的关系:炎症生物标志物及在早产儿中治疗策略作用的综述
Int J Mol Sci. 2022 Nov 10;23(22):13877. doi: 10.3390/ijms232213877.
6
Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia.支气管肺发育不良的间充质干细胞治疗的进展和剩余障碍。
Clin Respir J. 2022 Oct;16(10):629-645. doi: 10.1111/crj.13540. Epub 2022 Sep 2.
7
An Update on the Prevention and Management of Bronchopulmonary Dysplasia.支气管肺发育不良的预防与管理最新进展
Pediatric Health Med Ther. 2021 Aug 11;12:405-419. doi: 10.2147/PHMT.S287693. eCollection 2021.
8
Related Factors of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis.早产儿动脉导管未闭的相关因素:一项系统评价和Meta分析
Front Pediatr. 2021 Jan 5;8:605879. doi: 10.3389/fped.2020.605879. eCollection 2020.
9
Conservative Non-intervention Approach for Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants.极低出生体重早产儿血流动力学显著的动脉导管未闭的保守非干预方法
Front Pediatr. 2020 Dec 23;8:605134. doi: 10.3389/fped.2020.605134. eCollection 2020.
10
Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria.母亲对扑热息痛的摄入与胎儿动脉导管收缩/闭锁:使用奥斯汀·布拉德福德·希尔标准进行综合信号评估。
Eur J Clin Pharmacol. 2021 Jul;77(7):1019-1028. doi: 10.1007/s00228-020-03039-z. Epub 2021 Jan 7.